EGFR and gastric cancer: Bandres et al. [94] reported that miR-451 functions as a tumor suppressor by repressing migration inhibitory factor (MIF), thereby activating Bcl-2, EGFR (epidermal growth factor receptor) and the phosphoinositide 3-kinase (PI3K)/Akt pathway in GC [95,96].